Differentiated thyroid carcinomas may elude the immune system by B7H1 upregulation

The Common  -Chain Cytokines IL-2, IL-7, IL-15, and IL-21 Induce the Expression of Programmed Death-1 and Its Ligands

(2014) A. L. Kinter et al.   JOURNAL OF IMMUNOLOGY

Infiltration of a mixture of different immune cells may be related to molecular profile of differentiated thyroid cancer

(2012) Lucas Leite Cunha et al.   ENDOCRINE-RELATED CANCER

Phenotypical Analysis of Lymphocytes with Suppressive and Regulatory Properties (Tregs) and NK Cells in the Papillary Carcinoma of Thyroid

(2012) Foteini Gogali et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Programmed Death-1+T Cells and Regulatory T Cells Are Enriched in Tumor-Involved Lymph Nodes and Associated with Aggressive Features in Papillary Thyroid Cancer

(2012) Jena D. French et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

B7-H1 expression is associated with expansion of regulatory T cells in colorectal carcinoma

(2012) Dong Hua   WORLD JOURNAL OF GASTROENTEROLOGY

Upregulation of B7-H1 expression is associated with macrophage infiltration in hepatocellular carcinomas

(2011) Jie Chen et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Immunoregulatory Molecule B7-H1 (CD274) Contributes to Skin Carcinogenesis

(2011) Y. Cao et al.   CANCER RESEARCH

Hallmarks of Cancer: The Next Generation

(2011) Douglas Hanahan et al.   CELL

Use of sodium iodide symporter expression in differentiated thyroid carcinomas

(2011) Elaine C. Morari et al.   CLINICAL ENDOCRINOLOGY

Concurrent lymphocytic thyroiditis is associated to less aggressive papillary thyroid carcinomas

(2011) Lucas Leite Cunha et al.   EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY

Reduced tumor-antigen density leads to PD-1/PD-L1-mediated impairment of partially exhausted CD8+ T cells

(2011) Andrew D. Kaiser et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Tumor cell expression of programmed cell death-1 ligand 1 is a prognostic factor for malignant melanoma

(2010) Ryosuke Hino et al.   CANCER

Overall survival and PD-L1 expression in metastasized malignant melanoma

(2010) Jules Gadiot et al.   CANCER

B7-H1 Overexpression Regulates Epithelial–Mesenchymal Transition and Accelerates Carcinogenesis in Skin

(2010) Yujia Cao et al.   CANCER RESEARCH

Muc-1 Expression May Help Characterize Thyroid Nodules but Does Not Predict Patients’ Outcome

(2010) Elaine Cristina Morari et al.   ENDOCRINE PATHOLOGY

PD-L1 expression on tolerogenic APCs is controlled by STAT-3

(2010) Sabine J. Wölfle et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Tumor-Associated Lymphocytes and Increased FoxP3+Regulatory T Cell Frequency Correlate with More Aggressive Papillary Thyroid Cancer

(2010) Jena D. French et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Clinical Significance of B7-H1 and B7-1 Expressions in Pancreatic Carcinoma

(2010) Liancai Wang et al.   WORLD JOURNAL OF SURGERY

Automated Cellular Imaging System III for Assessing HER2 Status in Breast Cancer Specimens

(2009) Douglas M. Minot et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

FOXP3 Expression and Overall Survival in Breast Cancer

(2009) Andrea Merlo et al.   JOURNAL OF CLINICAL ONCOLOGY

B7-H1 is correlated with malignancy-grade gliomas but is not expressed exclusively on tumor stem-like cells

(2009) Yu Yao et al.   NEURO-ONCOLOGY

Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer

(2009) David S. Cooper et al.   THYROID

B7-H1 Expression in Wilms Tumor: Correlation With Tumor Biology and Disease Recurrence

(2008) Jonathan C. Routh et al.   JOURNAL OF UROLOGY